Beyond 5 years enduring risk of recurrence in oestrogen receptorpositive breast cancer

Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancer

18:26 EST 18 Dec 2018 | Nature Publishing

More From BioPortfolio on "Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancer"